MEDICATION GUIDE
ORILISSA® (awr-ah-lih-sah)
(elagolix)
tablets, for oral use |
What is the most important information I should know about ORILISSA?
ORILISSA may cause serious side effects, including:
-
bone loss (decreased bone mineral density).
○ While you are taking ORILISSA, your estrogen levels will be low. Low estrogen levels can lead to bone mineral density loss.
○ If you have bone loss on ORILISSA, your bone density may improve after you stop taking ORILISSA but complete recovery may not occur. It is unknown if these bone changes could increase your risk for broken bones as you age. For this reason, your healthcare provider may limit the length of time you take ORILISSA.
○ Your healthcare provider may advise you to take vitamin D and calcium supplements as part of a healthy lifestyle that promotes bone health.
○ If you have conditions or take other medicines that can cause bone loss, or if you have broken a bone with minimal or no injury, your healthcare provider may order an X-ray test called a DXA scan to check your bone mineral density.
-
effects on pregnancy
○ Do not take ORILISSA if you are trying to become or are pregnant. It may increase the risk of early pregnancy loss.
○ If you think you are pregnant, stop taking ORILISSA right away and call your healthcare provider.
● If you become pregnant while taking ORILISSA, you are encouraged to enroll in the Pregnancy Registry. The purpose of the pregnancy registry is to collect information about the health of you and your baby. Contact the registry as soon as you learn that you are pregnant or ask your healthcare provider to contact the registry for you. You or your healthcare provider can get information and enroll you in the registry by calling 1-833-782-7241 or visiting https://www.bloompregnancyregistry.com.
○ ORILISSA may change your menstrual periods (irregular bleeding or spotting, a decrease in menstrual bleeding, or no bleeding at all), making it hard to know if you are pregnant. Watch for other signs of pregnancy such as breast tenderness, weight gain and nausea.
○ ORILISSA does not prevent pregnancy. You will need to use effective methods of birth control while taking ORILISSA and for 28 days after you stop taking ORILISSA. Examples of effective methods can include condoms or spermicide, which do not contain hormones.
○ Birth control pills that contain estrogen may make ORILISSA less effective. It is not known how well ORILISSA will work while you are taking progestin-only birth control such as injections or implants.
○ Talk to your healthcare provider about which birth control to use during treatment with ORILISSA. Your healthcare provider may change the birth control you were on before you start taking ORILISSA.
|
What is ORILISSA?
ORILISSA is a prescription medicine used to treat moderate to severe pain associated with endometriosis. It is not known if ORILISSA is safe and effective in children. |
Do not take ORILISSA if you:
- are pregnant
- have osteoporosis
- have severe liver disease
- are taking medicines called organic anion transporting polypeptide (OATP)1B1 inhibitors that are known or expected to significantly increase the blood levels of elagolix (the active ingredient in ORILISSA). Ask your healthcare provider if you are not sure if you are taking one of these medicines.
- have had a serious allergic reaction to ORILISSA or any of the ingredients in ORILISSA. See the end of this Medication Guide for a complete list of ingredients in ORILISSA. Ask your healthcare provider if you are not sure.
|
Before you take ORILISSA, tell your healthcare provider about all of your medical conditions, including if you:
- have or have had broken bones or other conditions that may cause bone problems
- have or have had depression, mood problems or suicidal thoughts or behavior
- have liver problems
- think you may be pregnant. You should avoid becoming pregnant while taking ORILISSA
- are breastfeeding or plan to breastfeed. It is not known if ORILISSA passes into your breastmilk. Talk to your healthcare provider about the best way to feed your baby if you take ORILISSA.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Especially tell your healthcare provider if you take:
- birth control that contains hormones. Your healthcare provider may advise you to change your method of birth control.
Know the medicines you take. Keep a list of your medicines with you to show to your healthcare provider and pharmacist when you get a new medicine. |
How should I take ORILISSA?
- Take ORILISSA exactly as your healthcare provider tells you to take it.
- Your healthcare provider will give you a pregnancy test before you start taking ORILISSA or will have you start taking ORILISSA within 7 days after you start your period.
- If your healthcare provider prescribes:
○ ORILISSA 150 mg (a pink tablet), take it 1 time each day
○ ORILISSA 200 mg (an orange tablet), take it 2 times each day
- Take ORILISSA at about the same time each day with or without food.
- If you take too much ORILISSA, call your healthcare provider or go to the nearest hospital emergency room right away.
- If you miss a dose of ORILISSA:
○ 150 mg (1 time each day), take it as soon as you remember as long as it is on the same day. Do not take more than 1 tablet each day.
○ 200 mg (2 times each day), take it as soon as you remember as long as it is on the same day. Do not take more than 2 tablets each day.
|
What are the possible side effects of ORILISSA?
ORILISSA may cause serious side effects including:
- See “What is the most important information I should know about ORILISSA?”
-
suicidal thoughts, suicidal behavior, and worsening of mood. ORILISSA may cause suicidal thoughts or actions. Call your healthcare provider or get emergency medical help right away if you have any of the following symptoms, especially if they are new, worse, or bother you:
○ thoughts about suicide or dying
○ attempts to commit suicide
○ new or worse depression
○ new or worse anxiety
○ other unusual changes in behavior or mood
You or your caregiver should pay attention to any changes, especially sudden changes in your mood, behaviors, thoughts, or feelings.
-
abnormal liver tests. Call your healthcare provider right away if you have any of these signs and symptoms of liver problems:
○ yellowing of the skin or the whites of the eyes (jaundice)
○ dark amber-colored urine
○ feeling tired (fatigue or exhaustion)
○ nausea and vomiting
○ generalized swelling
○ right upper stomach area (abdomen) pain
○ bruising easily
The most common side effects of ORILISSA include: hot flashes and night sweats, headache, nausea, difficulty sleeping, absence of periods, anxiety, joint pain, depression and mood changes.
These are not all the possible side effects of ORILISSA. Call your healthcare provider for medical advice about side effects.
You may report side effects to FDA at 1-800-FDA-1088. |
How should I store ORILISSA?
- Store ORILISSA between 36°F to 86°F (2°C to 30°C).
-
Do not keep medicine that is out of date or that you no longer need.
- Throw away (dispose of) unused medicines through community take-back disposal programs when available. If no community take-back disposal program is available go to www.fda.gov/drugdisposal for more information on how to dispose of ORILISSA the right way.
-
Do not flush ORILISSA down the toilet.
-
Keep ORILISSA and all medicines out of the reach of children.
|
General information about the safe and effective use of ORILISSA.
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use ORILISSA for a condition for which it was not prescribed. Do not give ORILISSA to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about ORILISSA that is written for health professionals. |
What are the ingredients in ORILISSA?
Active ingredient: elagolix
Inactive ingredients 150 mg tablets: mannitol, sodium carbonate monohydrate, pregelatinized starch, povidone, magnesium stearate, polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc, and carmine high tint.
Inactive ingredients 200 mg tablets: mannitol, sodium carbonate monohydrate, pregelatinized starch, povidone, magnesium stearate, polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc, and iron oxide red.
Manufactured by
AbbVie Inc.
North Chicago, IL 60064
20075867
For more information, go to www.orilissa.com or call 1-844-674-3676. |